Skip to main content
. 2018 Nov 13;19(11):3583. doi: 10.3390/ijms19113583
AP Action potential
APDxx Action potential duration at xx%
hiPSC Human induced pluripotent stem cell
APA Action potential amplitude
DAD Delayed afterdepolarization
dV/dtmax Maximum upstroke velocity
EAD Early afterdepolarization
EHT Engineered heart tissue
FDA Food and drug administration
hiPSC-CM Human induced pluripotent stem cell-derived cardiomyocyte
ICaL L-type Ca2+ current
If Funny current
IKr Rapid delayed rectifying K+ current
IKs Slow delayed rectifying K+ current
IK1 Inward rectifying K+ current
INa Fast Na+ current
INaK Na+/K+ pump
INaL Late Na+ current
INCX Na+/Ca2+ exchanger
IpCa Sarcolemmal Ca2+ pump
IRyR RyR-sensitive Ca2+ release
ISERCA SERCA pump
Ito Transient outward K+ current
LB Lower bound
LQT1_CTRL hiPSC-CM population with control IKs from [3]
LQT1_MUT hiPSC-CM population with mutant IKs from [3]
LQT2_CTRL hiPSC-CM population with control IKr from [4]
LQT2_MUT hiPSC-CM population with mutant IKr from [4]
MDP Maximum diastolic potential
mean Mean value
Paci2018 hiPSC-CM model from [20]
Peak Peak potential
Rate Spontaneous action potential rate
SD Standard deviation
UB Upper bound
ΔAPD90% Percent APD90 variation